XML 52 R36.htm IDEA: XBRL DOCUMENT v3.22.1

Note 14 - Segment Data (Tables)

12 Months Ended

Mar. 31, 2022

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

		Year Ended March 31,
		2022				2021				2020
Revenues (a):
Sterilization and Disinfection Control		$	59,044			$	53,119			$	49,660
Biopharmaceutical Development			45,579				33,892				13,851
Calibration Solutions			46,872				46,926				51,713
Clinical Genomics			32,840				-				-
Reportable segment revenues			184,335				133,937				115,224
Corporate and Other (b)			-				-				2,463
Total revenues		$	184,335			$	133,937			$	117,687
Gross profit:
Sterilization and Disinfection Control		$	43,720			$	39,870			$	35,797
Biopharmaceutical Development			28,605				21,035				382
Calibration Solutions			24,989				26,112				28,765
Clinical Genomics			11,941				-				-
Reportable segment gross profit			109,255				87,017				64,944
Corporate and Other (b)			(165	)			(3	)			418
Gross profit		$	109,090			$	87,014			$	65,362
Reconciling items:
Operating expenses			104,388				74,656				57,439
Operating income			4,702				12,358				7,923
Nonoperating expense			1,128				10,055				4,061
Earnings before income taxes		$	3,574			$	2,303			$	3,862

		March 31,				March 31,
		2022				2021
Sterilization and Disinfection Control		$	2,176			$	2,333
Biopharmaceutical Development			4,495				4,162
Calibration Solutions			6,133				4,683
Clinical Genomics			11,802				-
Reportable segment inventory			24,606				11,178
Corporate and Other			-				-
Total inventories, net		$	24,606			$	11,178

Long-Lived Assets by Geographic Areas [Table Text Block]

		As of March 31,
		2022				2021
United States		$	36,475			$	21,443
Foreign			3,975				3,085
Total		$	40,450			$	24,528

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]

		Year Ended March 31,
		2022				2021				2020
United States		$	99,068			$	71,387			$	66,344
Foreign			85,267				62,550				51,343
Total revenues		$	184,335			$	133,937			$	117,687

X

- Definition

Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph b
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

+ Details

Name:	us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

+ Details

Name:	us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration